Electronic medical records can be used to emulate target trials of sustained treatment strategies
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective To emulate three target trials: single treatment versus no treatment, joint treatment versus no treatment, and head-to-head comparison of two treatments. We explain how to estimate the observational analogs of intention-to-treat and per-protocol effects, using hazard ratios and survival curves. For per-protocol effects, we describe two methods for adherence adjustment via inverse-probability weighting. Study Design and Setting Prospective observational study using electronic medical records of individuals aged 55–84 with coronary heart disease from >500 practices in the United Kingdom between 2000–2010. Results The intention-to-treat mortality hazard ratio (95% confidence interval) was 0.90 (0.84, 0.97) for statins versus no treatment, 0.88 (0.73, 1.06) for statins plus antihypertensives versus no treatment, and 0.91 (0.77, 1.06) for atorvastatin versus simvastatin. When censoring non-adherent person-times, the per-protocol mortality hazard ratio was 0.74 (0.64, 0.85) for statins versus no treatment, 0.55 (0.35, 0.87) for statins plus antihypertensives versus no treatment, and 1.13 (0.88, 1.45) for atorvastatin versus simvastatin. We estimated per-protocol hazard ratios for a 5-year treatment using different dose-response marginal structural models, and standardized survival curves for each target trial using intention-to-treat and per-protocol analyses. Conclusion When randomized trials are not available or feasible, observational analyses can emulate a variety of target trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efron, B., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013815 · Cited by 6,033
Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 1×
“An explicit emulation prevents biases such as prevalent user bias (13) and immortal time bias (14), and helps define the observational analog of per-protocol effects.”
BackgroundHernán, M. A., Sauer, B. C., Hernández-Díaz, S., Platt, R., & Shrier, I. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.04.014 · Cited by 1,097 · cited 1×
“An explicit emulation prevents biases such as prevalent user bias (13) and immortal time bias (14), and helps define the observational analog of per-protocol effects.”
BackgroundSelf-citationPer-Protocol Analyses of Pragmatic Trials
Hernán, M. A., & Robins, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmsm1605385 · Cited by 660 · cited 1×
“(22) Unfortunately, as we did not have data on the reasons to change treatment, our per-protocol effect estimates considered all deviations from the baseline treatment as non-adherence.”
BackgroundSelf-citationBeyond the intention-to-treat in comparative effectiveness research
Hernán, M. A., & Hernández-Díaz, S. (2012) · Clinical Trials · doi:10.1177/1740774511420743 · Cited by 528 · cited 1×
“Similar approaches to estimate per-protocol effects can be adopted in randomized trials (16).”
BackgroundSelf-citationMills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., & Briel, M. (2011) · QJM · doi:10.1093/qjmed/hcq165 · Cited by 338
Cited by
Evaluating eligibility criteria of oncology trials using real-world data and AI
Liu, R., Rizzo, S., Whipple, S., Pal, N., Pineda, A. L., Lu, M., Arnieri, B., Lu, Y., Capra, W., Copping, R., et al. (2021) · Nature · doi:10.1038/s41586-021-03430-5 · Cited by 322
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. (2021) · JAMA · doi:10.1001/jama.2021.6530 · Cited by 191
Effectiveness of Localized Lockdowns in the COVID-19 Pandemic
Li, Y., Undurraga, E. A., & Zubizarreta, J. R. (2020) · doi:10.1101/2020.08.25.20182071 · Cited by 58
Emulating a target trial of statin use and risk of dementia using cohort data
Caniglia, E. C., Rojas-Saunero, L. P., Hilal, S., Licher, S., Logan, R., Stricker, B., Ikram, M. A., & Swanson, S. A. (2020) · Neurology · doi:10.1212/wnl.0000000000010433 · Cited by 56
Self-citationMaust, D. T., Petzold, K., Strominger, J., Kim, H. M., & Bohnert, A. S. B. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.48557 · Cited by 47
Metadata
- Authors
- Danaei, G., García Rodríguez, L. A., Cantero, O. F., Logan, R. W., & Hernán, M. A.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 96
- Pages
- 12-22
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2774818507
- Cited by
- 130
- References
- 8
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electronic medical records can be used to emulate target trials of sustained treatment strategies. https://app.cochat.ai/papers/10.1016/j.jclinepi.2017.11.021
- The paper
- Danaei, G., García Rodríguez, L. A., Cantero, O. F., Logan, R. W., & Hernán, M. A. (2018). Electronic medical records can be used to emulate target trials of sustained treatment strategies. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2017.11.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.